Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway

Journal of Virology

Volumn 82, Issue 24, 2008, Pages 12535-12542

  Renukaradhya, Gourapura J ^b   Khan, Masood A ^b   Shaji, Daniel ^b   Brutkiewicz, Randy R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; CELL LINE; ENZYME ACTIVATION; MAP KINASE SIGNALING SYSTEM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TRANSPORT; VESICULOVIRUS; VIRAL MATRIX PROTEINS;

MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 57349190168     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00881-08     Document Type: Article

References (65)

1. Ahmed, M., S. D. Cramer, and D. S. Lyles. 2004. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology 330:34-49.
2. Ahmed, M., and D. S. Lyles. 1998. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J. Virol. 72:8413-8419.
3. Andrade, A. A., P. N. Silva, A. C. Pereira, L. P. De Sousa, P. C. Ferreira, R. T. Gazzinelli, E. G. Kroon, C. Ropert, and C. A. Bonjardim. 2004. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem. J. 381:437-446.
4. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77:10168-10171.
5. Bacik, I., J. H. Cox, R. Anderson, J. W. Yewdell, and J. R. Bennink. 1994. TAP (transporter associated with antigen processing)- independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino but not carboxyl terminus of the peptide. J. Immunol. 152:381-387.
6. + T lymphocytes. Science 268:863-865.
7. Black, B. L., and D. S. Lyles. 1992. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66:4058-4064.
8. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22:817-890.
9. Brossay, L., D. Jullien, S. Cardell, B. C. Sydora, N. Burdin, R. L. Modlin, and M. Kronenberg. 1997. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159:1216-1224.
10. + targets. J. Immunol. 160:3681-3688.
11. Brutkiewicz, R. R. 2006. CD1d ligands: the good, the bad, and the ugly. J. Immunol. 177:769-775.
12. 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182:1913-1919.
13. Brutkiewicz, R. R., Y. Lin, S. Cho, Y. K. Hwang, V. Sriram, and T. J. Roberts. 2003. CD1d-mediated antigen presentation to natural killer T (NKT) cells. Crit. Rev. Immunol. 23:403-419.
14. Brutkiewicz, R. R., and V. Sriram. 2002. Natural killer T (NKT) cells and their role in antitumor immunity. Crit. Rev. Oncol./Hematol. 41:287-298.
15. + NK T lymphocytes. J. Immunol. 161:3271-3281.
16. Calabi, F., and A. Bradbury. 1991 The CD1 system. Tissue Antigens 37:1-9.
17. Chen, N., C. McCarthy, H. Drakesmith, D. Li, V. Cerundolo, A. J. McMichael, G. R. Screaton, and X. N. Xu. 2006. HIV-1 down-regulates the expression of CD1d via Nef. Eur. J. Immunol. 36:278-286.
18. Cho, S., K. S. Knox, L. M. Kohli, J. J. He, M. A. Exley, S. B. Wilson, and R. R. Brutkiewicz. 2005. Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. Virology 337:242-252.
19. Connor, J. H., and D. S. Lyles. 2005. Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation. J. Biol. Chem. 280:13512-13519.
20. di Francesco, P., V. Sorrentino, A. Battistini, A. M. Curatola, and G. B. Rossi. 1987. L929 cells infected with temperature sensitive mutants of vesicular stomatitis virus: virus replication is necessary for induction of changes in membrane permeability. Arch. Virol. 97:225-236.
21. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72.
22. Duthie, M. S., M. Kahn, M. White, R. P. Kapur, and S. J. Kahn. 2005. Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 73:1890-1894.
23. Duthie, M. S., M. Kahn, M. White, R. P. Kapur, and S. J. Kahn. 2005. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 73:181-192.
24. Duthie, M. S., M. Wleklinski-Lee, S. Smith, T. Nakayama, M. Taniguchi, and S. J. Kahn. 2002. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70:36-48.
25. Exley, M. A., N. J. Bigley, O. Cheng, A. Shaulov, S. M. Tahir, Q. L. Carter, J. Garcia, C. Wang, K. Patten, H. F. Stills, F. W. Alt, S. B. Snapper, and S. P. Balk. 2003. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 110:519-526.
26. Exley, M. A., N. J. Bigley, O. Cheng, S. M. Tahir, S. T. Smiley, Q. L. Carter, H. F. Stills, M. J. Grusby, Y. Koezuka, M. Taniguchi, and S. P. Balk. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69:713-718.
27. Faria, P. A., P. Chakraborty, A. Levay, G. N. Barber, H. J. Ezelle, J. Enninga, C. Arana, J. van Deursen, and B. M. Fontoura. 2005. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 17:93-102.
28. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T-cell immunity to a coadministered protein. J. Exp. Med. 198:267-279.
29. Garcia-Sastre, A. 2002. Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses. Microbes Infect. 4:647-655.
30. Gaudier, M., Y. Gaudin, and M. Knossow. 2002. Crystal structure of vesicular stomatitis virus matrix protein. EMBO J. 21:2886-2892.
31. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T-cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195:617-624.
32. Huber, S., D. Sartini, and M. Exley. 2003. Role of CD1d in coxsackievirus B3-induced myocarditis. J. Immunol. 170:3147-3153.
33. Ilyinskii, P. O., R. Wang, S. P. Balk, and M. A. Exley. 2006. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. J. Virol. 80:7146-7158.
34. Jayawardena-Wolf, J., K. Benlagha, Y. H. Chiu, R. Mehr, and A. Bendelac. 2001. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897-908.
35. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76:4294-4303.
36. + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. J. Immunol. 33:3322-3330.
37. Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-869.
38. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
39. Lefrancios, L., and D. S. Lyles. 1982. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121:157-167.
40. Lin, Y., T. J. Roberts, P. M. Spence, and R. R. Brutkiewicz. 2005. Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. J. Leukoc. Biol. 77:151-158.
41. Lin, Y., T. J. Roberts, C. R. Wang, S. Cho, and R. R. Brutkiewicz. 2005. Long-term loss of canonical NKT cells following an acute virus infection. Eur. J. Immunol. 35:879-889.
42. Lyles, D. S. 2000. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol. Mol. Biol. Rev. 64:709-724.
43. Lyles, D. S., M. O. McKenzie, M. Ahmed, and S. C. Woolwine. 1996. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression. Virology 225:172-180.
44. Lyles, D. S., M. O. McKenzie, P. E. Kaptur, K. W. Grant, and W. G. Jerome. 1996. Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes. Virology 217:76-87.
45. Marques, J. T., and R. W. Carthew. 2007. A call to arms: coevolution of animal viruses and host innate immune responses. Trends Genet. 23:359-364.
46. Melki, R., Y. Gaudin, and D. Blondel. 1994. Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: possible implications in the viral cytopathic effect. Virology 202:339-347.
47. Miyahira, Y., M. Katae, K. Takeda, H. Yagita, K. Okumura, S. Kobayashi, T. Takeuchi, T. Kamiyama, Y. Fukuchi, and T. Aoki. 2003. Activation of natural killer T cells by α-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infect. Immun. 71:1234-1241.
48. Nieuwenhuis, E. E., T. Matsumoto, M. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8:588-593.
49. Porcelli, S. A., and R. L. Modlin. 1999. The CD1 system: antigen-presenting molecules for T-cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297-329.
50. Raftery, M. J., F. Winau, T. Giese, S. H. Kaufmann, U. E. Schaible, and G. Schonrich. 2008. Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur. J. Immunol. 38:668-679.
51. Raftery, M. J., F. Winau, S. H. Kaufmann, U. E. Schaible, and G. Schonrich. 2006. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J. Immunol. 177:6207- 6214.
52. Rahaus, M., N. Desloges, and M. H. Wolff. 2004. Replication of varicellazoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation. J. Gen. Virol. 85:3529-3540.
53. Renukaradhya, G. J., T. J. Webb, M. A. Khan, Y. L. Lin, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J. Immunol. 175:4301-4308.
54. Rigaut, K. D., D. E. Birk, and J. Lenard. 1991. Intracellular distribution of input vesicular stomatitis virus proteins after uncoating. J. Virol. 65:2622-2628.
55. Roberts, T. J., V. Sriram, P. M. Spence, M. Gui, K. Hayakawa, I. Bacik, J. R. Bennink, J. W. Yewdell, and R. R. Brutkiewicz. 2002. Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J. Immunol. 168:5409-5414.
56. Sanchez, D. J., J. E. Gumperz, and D. Ganem. 2005. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Investig. 115:1369-1378.
57. Schmieg, J., G. Gonzalez-Aseguinolaza, and M. Tsuji. 2003. The role of natural killer T cells and other T-cell subsets against infection by the preerythrocytic stages of malaria parasites. Microbes Infect. 5:499-506.
58. Simon, K. O., P. A. Whitaker-Dowling, J. S. Youngner, and C. C. Widnell. 1990. Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus. Virology 177:289-297.
59. Sriram, V., C. A. Willard, J. Liu, and R. R. Brutkiewicz. 2008. Importance of N-linked glycosylation in the functional expression of murine CD1d1. Immunology 123:272-281.
60. Stojdl, D. F., B. D. Lichty, B. R. tenOever, J. M. Paterson, A. T. Power, S. Knowles, R. Marius, J. Reynard, L. Poliquin, H. Atkins, E. G. Brown, R. K. Durbin, J. E. Durbin, J. Hiscott, and J. C. Bell. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275.
61. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483-513.
62. Timmins, J., R. W. Ruigrok, and W. Weissenhorn. 2004. Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues. FEMS Microbiol. Lett. 233:179-186.
63. Vilarinho, S., K. Ogasawara, S. Nishimura, L. L. Lanier, and J. L. Baron. 2007. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl. Acad. Sci. USA 104:18187-18192.
64. Webb, T. J., R. A. Litavecz, M. A. Khan, W. Du, J. Gervay-Hague, G. J. Renukaradhya, and R. R. Brutkiewicz. 2006. Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules. Eur. J. Immunol. 36:2595-2600.
65. Yuan, W., A. Dasgupta, and P. Cresswell. 2006. Herpes simplex virus evades natural killer T-cell recognition by suppressing CD1d recycling. Nat. Immunol. 7:835-842.